Capacity to Process 100-Plus Samples per Week, with 1.6x Lower Limit of Detection SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – unleashing tools to accelerate breakthroughs in human health – today announced the launch of the Hyperion+™ Imaging System, the new standard in high-plex spatial imaging, providing lower limits of […]
EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Vestaron Corporation, the leader in peptide-based crop protection, announced a strategic partnership to advance the development of pesticidal peptides as Active Ingredients (AIs) to improve the safety and efficacy of crop protection solutions for the global food supply. In this […]
Bruker launches novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF fleX using AmberGen’s HiPLEX-IHC peptide code antibody probes, combined with unbiased lipidomics, glycomics and metabolomics tissue imaging New Canopy CellScape™ single cell, highly quantitative spatial proteomic ChipCytometry™ platform features fully automated iterative staining using open-source antibodies for virtually unlimited immuno-oncology marker analysis on whole tissue […]
Today, Finnish Organ-On-Chip startup Finnadvance announced that they’ve secured a €1.2 million seed financing round led by Finnish investor Athensmed. Several existing investors, such as deep tech VC Voima Ventures and early-stage VC Icebreaker, are participating in the funding round. In addition, the funding also includes a new investor: Takoa Invest. Finnadvance is a biotechnology start-up […]
Transforming Multiomics Spatial Tissue Biology with the Power of MALDI Mass Spectrometry for Imaging Targeted Proteins, Lipids, Glycans and Metabolites WATERTOWN, Massachusetts – Boston-area life science technology company AmberGen Inc. today announced that it has closed a strategic investment by Bruker Corporation, one of the world’s leading scientific instrumentation and life-science solutions companies. AmberGen’s innovative […]
Extension of previous funding round brings total raised to £7 million GBP (circa $9.2 million USD) Investment from Calculus Capital, Par Equity, and Scottish Enterprise Funding will support continued development of Axol’s human iPS cell lines and reagents, and expansion of its commercial team Cambridge, UK: Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, […]
Launches first-of-its-kind automated ultrasound platform to accelerate preclinical research WALTHAM, Mass. — PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the expansion of its in vivo imaging portfolio with the launch of the Vega® imaging system, a first-of-its kind ultrasound platform that combines hands-free, automated technology with high-throughput capability to […]
MENLO PARK, Calif. — LevitasBio, Inc. today unveiled the LeviCell™ EOS System, their next generation solution for cell separation and enrichment, featuring higher throughput and simultaneous targeted selection of viable cells. Utilizing field proven Levitation Technology, researchers can now effectively scale their experiments up to 16x and process up to 40 million cells per run. The LeviCell EOS […]
The acquisition of the MAST® platform is another milestone to accelerate innovation in Merck’s Process Solutions business unit. Merck to become first company to offer a fully integrated ecosystem for advanced process technologies Brings biopharmaceutical industry closer to digitally enabled manufacturing facility of the future MAST® Platform provides real-time process information, cuts process development time by […]
Biospecimen Leader to Combine Gentest with Recent IVAL Acquisition to Create Leading In Vitro Drug Metabolism Services Offering HUNTSVILLE, Ala. — Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, announced today that it has acquired the Gentest® business unit, part of Corning Incorporated’s Life Sciences business. The acquisition of Gentest complements Discovery’s recent acquisition of In Vitro ADMET […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
